Anticancer drugs-induced apoptotic cell death in leukemia cells is associated with proteolysis of β-catenin

Leukemia Research

Volumn 26, Issue 9, 2002, Pages 863-871

  Hwang, Sang Gu ^a   Lee, Hyung Chul ^a   Trepel, Jane B ^b   Jeon, Byung Hun ^a  

^a Wonkwang University   (South Korea)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Apoptosis inducer; Catenin; Cell death; Cleavage; Leukemia cells; Transcription

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; CALPAIN; CASPASE; ETOPOSIDE; FAS ANTIBODY; LACTACYSTIN; MONOCLONAL ANTIBODY CH11; N ACETYLLEUCYLLEUCYLMETHIONINAL; PROTEASOME; PROTEINASE INHIBITOR; STAUROSPORINE; TRIPEPTIDE DERIVATIVE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; CTNNB1 PROTEIN, HUMAN; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; CYTOSKELETON PROTEIN; FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN; HYBRID PROTEIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MULTIENZYME COMPLEX; TRANSACTIVATOR PROTEIN; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; CELL TYPE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN DEGRADATION; WESTERN BLOTTING; CANCER STEM CELL; CELL STRAIN U937; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; BETA CATENIN; CALPAIN; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; CYTOSKELETAL PROTEINS; FAS LIGAND PROTEIN; HEMATOPOIETIC STEM CELLS; HUMANS; JURKAT CELLS; MEMBRANE GLYCOPROTEINS; MULTIENZYME COMPLEXES; NEOPLASM PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR STEM CELLS; U937 CELLS;

EID: 0035984438     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(02)00018-8     Document Type: Article

References (48)

1. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics
2. Cell death: the significance of apoptosis
3. Mechanisms and genes of cellular suicide
4. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview
5. Looking beneath the surface: the cell death pathway of Fas/APO-1 (CD95)
6. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
7. The Fas death factor
8. Toward an understanding of the molecular mechanisms of physiological cell death
9. Caspases: the proteases of the apoptotic pathway
10. Aoptosis: basic concepts and potential significance in human cancer
11. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme
12. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis
13. Human ICE/CED-3 protease nomenclature
14. ICE family proteases: mediators of all apoptotic cell death?
15. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
16. CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis
17. Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis
18. Cleavage of focal adhesion kinase by caspases during apoptosis
19. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis
20. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
21. Cleavage of retinoblastoma protein during apoptosis: an interleukin 1 beta-converting enzyme-like protease as candidate
22. Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of beta-catenin
23. Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases
24. Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis
25. Apoptosis-associated cleavage of beta-catenin in human colon cancer and rat hepatoma cells
26. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein
27. Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex
28. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor)
29. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma
30. Posttranslational regulation of the retinoblastoma gene family member p107 by calpain protease
31. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF
32. Inhibition of the 3-hydroxy-3-methylglutary coenzyme a reductase pathway induces p53-independent transcriptional regulation of p21WAF1/CIP1 in human prostate carcinoma cells
33. A novel ets-related transcription factor ERT/ESX/ESE-1 regulates expression of the transforming growth factor-b type II receptor
34. Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action
35. Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin
36. Nuclear beta-catenin displays GSK-3beta- and APC-independent proteasome sensitivity in melanoma cells
37. Monoclonal antibody-mediated tumor regression by induction of apoptosis
38. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor
39. Protein kinase C activation promotes cell survival in mature lymphocytes prone to apoptosis
40. Etoposide targets topoisomerase II alpha and II beta in leukemic cells: isoform-specific cleavable complexes visualized and quantified in situ by a novel immunofluorescence technique
41. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappa B
42. β-Catenin is a target for the ubiquitin-proteasome pathway
43. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin
44. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
45. On the involvement of calpains in the degradation of the tumor suppressor protein p53
46. Expression of cadherin-catenin complexes in human leukemia cell lines
47. Identification of c-MYC as a target of the APC pathway
48. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells